These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 9528753
1. Mechanisms of cyclin-dependent kinase inactivation by progestins. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL. Mol Cell Biol; 1998 Apr; 18(4):1812-25. PubMed ID: 9528753 [Abstract] [Full Text] [Related]
2. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J. Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267 [Abstract] [Full Text] [Related]
3. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
4. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
5. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. Musgrove EA, Hunter LJ, Lee CS, Swarbrick A, Hui R, Sutherland RL. J Biol Chem; 2001 Dec 14; 276(50):47675-83. PubMed ID: 11590147 [Abstract] [Full Text] [Related]
9. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver. Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS. Oncogene; 1998 Apr 23; 16(16):2141-50. PubMed ID: 9572495 [Abstract] [Full Text] [Related]
17. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Teixeira C, Pratt MA. Mol Endocrinol; 1997 Aug 23; 11(9):1191-202. PubMed ID: 9259311 [Abstract] [Full Text] [Related]
18. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice. Hampl A, Pacherník J, Dvorák P. Biol Reprod; 2000 May 23; 62(5):1393-401. PubMed ID: 10775192 [Abstract] [Full Text] [Related]
19. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]
20. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP. Mol Biol Cell; 2000 Mar 01; 11(3):1061-76. PubMed ID: 10712520 [Abstract] [Full Text] [Related] Page: [Next] [New Search]